Inventor · disambiguated record
Mathias Ferencic
Also filed as: FERENCIC MATHIAS
4 granted patents·11 pending applications·13 citations·filing 2004–2024
72Inventor score
Files withNabriva Therapeutics GmbH8MANG ROSEMARIE3NABRIVA THERAPEUTICS AG2ASCHER GERD1NABRIVA THERAPEUTICS FORSCHUNG1
Top patents by PatentIndex Score
15 records- 0183US8071643B2Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2008·Granted Dec 6, 2011·6 cites·11 claims
- 0280US8153689B2Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2011·Granted Apr 10, 2012·4 cites·5 claims
- 0373US7790767B2Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl groupNABRIVA THERAPEUTICS FORSCHUNG·Filed 2006·Granted Sep 7, 2010·3 cites·10 claims
- 0473US2022218713A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2022·Application pending·0 cites
- 0570US2021113571A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0668US2020281933A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0765US2025009885A1Injectable pharmaceutical formulations of lefamulinNabriva Therapeutics GmbH·Filed 2024·Application pending·0 cites
- 0864US2020030335A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 0963US2019175603A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 1063US2014256731A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2014·Application pending·0 cites
- 1161US2018303842A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2018·Application pending·0 cites
- 1261US2017266194A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 1358US2013040954A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2012·Application pending·0 cites
- 1450US12121582B2Injectable pharmaceutical formulations of lefamulinNabriva Therapeutics GmbH·Filed 2016·Granted Oct 22, 2024·0 cites·17 claims
- 1543US2008009470A1Acremonic Acid DerivativesASCHER GERD·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mathias Ferencic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →